Mesalamine Supplier-Buyer Network — Trade Flow Analysis

Name: Mesalamine Supplier-Buyer Trade Network Dataset — 103+ Indian Exporters, 10+ Importers, 51+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Mesalamine supplier network, Mesalamine buyers, pharmaceutical export India, Mesalamine trade data

TransData Nexus

Mesalamine

India Pharmaceutical Trade Intelligence

$1.3B103 Suppliers51 CountriesHS 30049099

ExportsIndia → UNITED STATES98.6%India → RUSSIA0.4%

ImportsUNITED STATES → India$1.0M ISRAEL → India$27.3K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Who Supplies Mesalamine? Top Manufacturers & Buyers 2026 — ZYDUS LIFESCIENCES LIMITED Leads | TransData Nexus | TransData Nexus

1ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the first-largest Mesalamine exporter from India, with a market share of 72.3% and a total export value of $954.0M across 386 shipments. Their average shipment value of $2.5M is above the market average of $349.1K, suggesting premium or bulk contract pricing.

ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES, is the dominant customer, accounting for 98.5% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES, — $939.5M across 380 shipments (98.5% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER — $13.1M across 5 shipments (1.4% of this supplier's total exports)

• ZYDUS NIKKHO FARMACE — $565.9K across 0 shipments (0.1% of this supplier's total exports)

• CEDIS CPA — $448.6K across 0 shipments (0.0% of this supplier's total exports)

• ZYDUS PHARMACEUTICAL — $407.8K across 0 shipments (0.0% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $2.5M is 608% above the market average of $349.1K, consistent with large-order contracts or value-added formulations.

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Mesalamine exporter from India, with a market share of 12.6% and a total export value of $166.8M across 207 shipments. Their average shipment value of $805.8K is above the market average of $349.1K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. SUN PHARMACEUTICAL INDUSTRIES,INC, is the dominant customer, accounting for 89.1% of this supplier's tracked business. Top customers include:

• SUN PHARMACEUTICAL INDUSTRIES,INC, — $148.6M across 184 shipments (89.1% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES,INC, — $7.3M across 9 shipments (4.4% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES,INC, — $4.0M across 5 shipments (2.4% of this supplier's total exports)

• XXN PXXRMAXXUTIXXL IXXUSTXXES XXC — $4.0M across 5 shipments (2.4% of this supplier's total exports)

• AO RANBAXY — $2.9M across 4 shipments (1.8% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $805.8K is 131% above the market average of $349.1K, consistent with large-order contracts or value-added formulations.

3CADILA HEALTHCARE LIMITED

CADILA HEALTHCARE LIMITED is the third-largest Mesalamine exporter from India, with a market share of 3.5% and a total export value of $46.4M across 32 shipments. Their average shipment value of $1.4M is above the market average of $349.1K, suggesting premium or bulk contract pricing.

CADILA HEALTHCARE LIMITED serves 2 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES, is the dominant customer, accounting for 95.3% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES, — $44.2M across 30 shipments (95.3% of this supplier's total exports)

• NORTHSTAR DISTRIBUTION CENTER — $2.2M across 2 shipments (4.7% of this supplier's total exports)

Key Insight: CADILA HEALTHCARE LIMITED's per-shipment value of $1.4M is 315% above the market average of $349.1K, consistent with large-order contracts or value-added formulations.

4ANNORA PHARMA PRIVATE LIMITED

ANNORA PHARMA PRIVATE LIMITED is the fourth-largest Mesalamine exporter from India, with a market share of 1.2% and a total export value of $15.6M across 157 shipments. Their average shipment value of $99.4K is below the market average of $349.1K, reflecting a high-volume, competitive pricing strategy.

ANNORA PHARMA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER OF — $7.0M across 71 shipments (45.1% of this supplier's total exports)

• TO THE ORDER OF — $5.8M across 58 shipments (36.9% of this supplier's total exports)

• TO THE ORDER — $1.2M across 12 shipments (7.5% of this supplier's total exports)

• CAMBER PHARMACEUTICA — $896.8K across 9 shipments (5.7% of this supplier's total exports)

• TO THE ORDER — $740.4K across 7 shipments (4.7% of this supplier's total exports)

Key Insight: ANNORA PHARMA PRIVATE LIMITED operates with high shipment frequency (157 shipments) at a per-shipment value of $99.4K, indicating a broad distribution network with many smaller, regular orders.

5CADILA HEALTHCARE LTD

CADILA HEALTHCARE LTD is the fifth-largest Mesalamine exporter from India, with a market share of 0.7% and a total export value of $9.7M across 9 shipments. Their average shipment value of $1.1M is above the market average of $349.1K, suggesting premium or bulk contract pricing.

CADILA HEALTHCARE LTD serves 2 named buyers in our database. EVERSANA LIFE SCIENCE SERVICES, is the dominant customer, accounting for 98.4% of this supplier's tracked business. Top customers include:

• EVERSANA LIFE SCIENCE SERVICES, — $9.6M across 9 shipments (98.4% of this supplier's total exports)

• ZYDUS PHARMACEUTICAL — $157.5K across 0 shipments (1.6% of this supplier's total exports)

Key Insight: CADILA HEALTHCARE LTD's per-shipment value of $1.1M is 210% above the market average of $349.1K, consistent with large-order contracts or value-added formulations.

6SUN PHARMACEUTICAL INDUSTRIES LTD

SUN PHARMACEUTICAL INDUSTRIES LTD is the fifth-largest Mesalamine exporter from India, with a market share of 0.3% and a total export value of $4.3M across 15 shipments. Their average shipment value of $287.9K is below the market average of $349.1K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LTD serves 2 named buyers in our database. SUN PHARMACEUTICAL INDUSTRIES,INC, is the dominant customer, accounting for 98.4% of this supplier's tracked business. Top customers include:

• SUN PHARMACEUTICAL INDUSTRIES,INC, — $4.2M across 15 shipments (98.4% of this supplier's total exports)

• SUN PHARMA ANZ PTY LTD — $70.7K across 0 shipments (1.6% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LTD operates with high shipment frequency (15 shipments) at a per-shipment value of $287.9K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Mesalamine imports from India, with a total trade value of $1.3B across 563 shipments — representing a 98.6% share of all Mesalamine exports. The average shipment value of $2.3M is above the global average of $349.1K, indicating high-value procurement contracts or branded formulations. This market is served by 13 tracked buyers.

Named Mesalamine importers in United States: EVERSANA LIFE SCIENCE SERVICES is the largest buyer, accounting for 82.1% ($1.1B) of this market's total imports.

• EVERSANA LIFE SCIENCE SERVICES — $1.1B (82.1% of United States's total)

• SUN PHARMACEUTICAL INDUSTRIES, INC. — $148.6M (11.4% of United States's total)

• NORTHSTAR DISTRIBUTION CENTER 8912 — $13.1M (1.0% of United States's total)

Key Insight: United States's per-shipment average of $2.3M (562% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Mesalamine imports from India.

Primary Market

Secondary Market

2Russia

Russia ranks as the second-largest destination for Mesalamine imports from India, with a total trade value of $5.3M across 36 shipments — representing a 0.4% share of all Mesalamine exports. The average shipment value of $146.9K is below the global average of $349.1K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Mesalamine importers in Russia: AO RANBAXY is the largest buyer, accounting for 55.5% ($2.9M) of this market's total imports.

• AO RANBAXY — $2.9M (55.5% of Russia's total)

• AO "RANBAXY" — $2.2M (40.8% of Russia's total)

Key Insight: Russia receives frequent, smaller shipments of Mesalamine — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Russia is a key market for Mesalamine imports from India.

Primary Market

Secondary Market

3Algeria

Algeria ranks as the third-largest destination for Mesalamine imports from India, with a total trade value of $4.2M across 0 shipments — representing a 0.3% share of all Mesalamine exports. The average shipment value of $4.2M is above the global average of $349.1K, indicating high-value procurement contracts or branded formulations.

Key Insight: Algeria's per-shipment average of $4.2M (1113% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Algeria is a key market for Mesalamine imports from India.

Primary Market

Secondary Market

4Australia

Australia ranks as the fourth-largest destination for Mesalamine imports from India, with a total trade value of $2.3M across 11 shipments — representing a 0.2% share of all Mesalamine exports. The average shipment value of $211.4K is below the global average of $349.1K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Mesalamine importers in Australia: SUN PHARMA ANZ PTY LIMITED is the largest buyer, accounting for 54.9% ($1.3M) of this market's total imports.

• SUN PHARMA ANZ PTY LIMITED — $1.3M (54.9% of Australia's total)

• SUN PHARMA ANZ PTY LTD — $1.1M (45.1% of Australia's total)

Key Insight: Australia receives frequent, smaller shipments of Mesalamine — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Australia is a key market for Mesalamine imports from India.

Primary Market

Secondary Market

5Mexico

Mexico ranks as the fifth-largest destination for Mesalamine imports from India, with a total trade value of $1.4M across 0 shipments — representing a 0.1% share of all Mesalamine exports. The average shipment value of $1.4M is above the global average of $349.1K, indicating high-value procurement contracts or branded formulations.

Key Insight: Mexico's per-shipment average of $1.4M (303% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Mexico is a key market for Mesalamine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Mesalamine.
2.Flow Mapping: 103 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,779 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 51 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,779 Verified Shipments

103 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Mesalamine

Mesalamine

Who Supplies Mesalamine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Mesalamine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Mesalamine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ZYDUS LIFESCIENCES LIMITED

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

3CADILA HEALTHCARE LIMITED

4ANNORA PHARMA PRIVATE LIMITED

5CADILA HEALTHCARE LTD

6SUN PHARMACEUTICAL INDUSTRIES LTD

From Indian Factories to Global Pharmacies — How Mesalamine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Mesalamine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Russia

3Algeria

4Australia

5Mexico

People Also Ask — Mesalamine Supplier & Trade Network

Mesalamine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology